ReShape Lifesciences Inc. (NASDAQ:RSLS – Free Report)’s stock is scheduled to reverse split on Monday, September 23rd. The 1-58 reverse split was announced on Thursday, September 19th. The number of shares owned by shareholders will be adjusted after the market closes on Friday, September 20th.
ReShape Lifesciences Price Performance
NASDAQ RSLS opened at $0.11 on Friday. The business has a fifty day moving average price of $0.18 and a 200 day moving average price of $0.18. ReShape Lifesciences has a one year low of $0.11 and a one year high of $0.67.
ReShape Lifesciences (NASDAQ:RSLS – Get Free Report) last released its earnings results on Wednesday, August 14th. The medical device company reported ($0.06) earnings per share (EPS) for the quarter. The business had revenue of $1.97 million for the quarter. ReShape Lifesciences had a negative return on equity of 208.37% and a negative net margin of 112.11%.
Analyst Ratings Changes
Check Out Our Latest Stock Report on ReShape Lifesciences
About ReShape Lifesciences
ReShape Lifesciences Inc provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; Lap-Band 2.0 System, an adjustable postoperatively to increase or decrease the pressure to the band in order to optimize an individual's comfort and therapy effectiveness; and ReShape Calibration Tubes, that fits the lesser curvature of the stomach to reach the pylorus.
Read More
- Five stocks we like better than ReShape Lifesciences
- How to Invest in Biotech Stocks
- Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut
- How to Evaluate a Stock Before Buying
- FedEx Stock Dips: Another Reason to Fear Recession Is Near
- Where to Find Earnings Call Transcripts
- The Half-Penny Revolution: Will SEC’s Reform Benefit Investors?
Receive News & Ratings for ReShape Lifesciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReShape Lifesciences and related companies with MarketBeat.com's FREE daily email newsletter.